426 related articles for article (PubMed ID: 8558976)
1. [Transmembrane Na+ transport kinetics in arterial hypertension: relations with vascular risk parameters].
Caballero Oliver A; Stiefel García-Junco P; García-Donas López MA; Villar Ortiz J; Carneado de la Fuente J
Med Clin (Barc); 1995 Dec; 105(20):768-73. PubMed ID: 8558976
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
Lijnen P; Fenyvesi A
Methods Find Exp Clin Pharmacol; 1994; 16(1):37-47. PubMed ID: 8164472
[TBL] [Abstract][Full Text] [Related]
3. [Abnormal erythrocyte sodium transport in patients with adult polycystic kidney and hypertension].
Guarena C; Boero R; Quarello F; Berto I; Muraca R; Roux V; Iadarola G; Piccoli G
Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1241-3. PubMed ID: 8129535
[TBL] [Abstract][Full Text] [Related]
4. [Activity of the systems of transmembrane transport of Na+ (Na+-K+ ATPase, Na+-K+-Cl cotransport, Na+-Li+ countertransport and passive Na+ diffusion) in essential arterial hypertension].
de la Sierra A; Coca A; Aguilera MT; Vives JL; Ingelmo M; Urbano-Márquez A
Med Clin (Barc); 1988 Feb; 90(5):186-9. PubMed ID: 2832663
[No Abstract] [Full Text] [Related]
5. [Transmembrane sodium transport systems in various forms of hyperlipoproteinemia].
Saitta A; Saitta MN; Messina A; Bonaiuto M; Castaldo M; Cinquegrani M; Imbalzano E; Mangano C; Giordano G; Vollero G; Sardo A; Totaro S
Minerva Med; 1996 Oct; 87(10):449-54. PubMed ID: 8992406
[TBL] [Abstract][Full Text] [Related]
6. Relationship of red blood cell ion transport alterations and serum lipid abnormalities in Lyon genetically hypertensive rats.
Zicha J; Dobesová Z; Kunes J; Vincent M
Can J Physiol Pharmacol; 1997 Sep; 75(9):1123-8. PubMed ID: 9365824
[TBL] [Abstract][Full Text] [Related]
7. A classification of essential hypertensive patients according to the erythrocyte Na transport abnormalities: an application for monitoring the antihypertensive response to cicletanide.
Garay R; Nazaret C; Hannaert P; Price M; Diez J; Dagher G; Deschamps de Paillette E; Juin G; Braquet P
Klin Wochenschr; 1985; 63 Suppl 3():30-2. PubMed ID: 2582180
[TBL] [Abstract][Full Text] [Related]
8. [Sodium transport in red blood cell membranes in essential arterial hypertension].
Giménez MI; Grunfeld B; Simsolo R; Mayorga M; Becú L
Medicina (B Aires); 1989; 49(6):589-94. PubMed ID: 2487432
[TBL] [Abstract][Full Text] [Related]
9. Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension.
Kedzierska K; Bober J; Ciechanowski K; Gołembiewska E; Kwiatkowska E; Noceń I; Dołegowska B; Dutkiewicz G; Chlubek D
Biol Trace Elem Res; 2005 Oct; 107(1):21-32. PubMed ID: 16170219
[TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
11. Circulating inhibitors of sodium transport at the prehypertensive stage of essential hypertension.
Haupert GT
J Cardiovasc Pharmacol; 1988; 12 Suppl 3():S70-6. PubMed ID: 2467109
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte cation fluxes in essential hypertension of children and adolescents.
Mongeau JG
Int J Pediatr Nephrol; 1985; 6(1):41-6. PubMed ID: 3997372
[TBL] [Abstract][Full Text] [Related]
13. [Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension].
Saitta A; Saitta MN; Messina A; Bonaiuto M; Cinquegrani M; Squadrito G; Castaldo M; Sardo A; Imbalzano E; Squadrito F
Minerva Med; 1997; 88(7-8):275-82. PubMed ID: 9304069
[TBL] [Abstract][Full Text] [Related]
14. [Trans-membrane cationic flow and hemodialysis].
Sechi LA; Orecchioni C; Melis A; Pala A; Tedde R
Boll Soc Ital Biol Sper; 1990 Oct; 66(10):1001-8. PubMed ID: 1710902
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous derangement of cellular sodium metabolism in Bartter's syndrome. Description of two cases and review of the literature.
Sechi LA; Melis A; Faedda R; Tedde R; Bartoli E
Panminerva Med; 1992; 34(2):85-92. PubMed ID: 1408334
[TBL] [Abstract][Full Text] [Related]
16. G-protein beta3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension.
Poch E; González-Núñez D; Compte M; De la Sierra A
Br J Biomed Sci; 2002; 59(2):101-4. PubMed ID: 12113397
[TBL] [Abstract][Full Text] [Related]
17. [Erythrocyte cation transport in arterial hypertension: interrelation with the renin-angiotensin-aldosterone system and the atrial natriuretic factor].
Manunta P; Melis MG; Soro A; Pazzola A; Troffa C; Motzo S; Pala F; Madeddu P; Tonolo G; Glorioso N
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1009-16. PubMed ID: 2560922
[TBL] [Abstract][Full Text] [Related]
18. Na+,K+,Cl- cotransport is a marker of distal tubular function in essential hypertension.
Righetti M; Cusi D; Stella P; Rivera R; Bernardi L; del Vecchio L; Bianchi G
J Hypertens; 1995 Dec; 13(12 Pt 2):1775-8. PubMed ID: 8903650
[TBL] [Abstract][Full Text] [Related]
19. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity.
Carr SJ; Sikand K; Moore D; Norman RI
J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of determining Na-Li countertransport in the diagnosis of arterial hypertension associated with minor urinary syndrome].
Eliseev AO; Arabidze GG; Petrov VV; Kukharchuk VV; Kaĭkov MI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):37-40. PubMed ID: 3401339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
